Inari Medical Announces First Patient Treated with the ClotTriever™ Thrombectomy System; FDA 510(k) Clearance Received for Peripheral Thrombectomy

IRVINE, CALIFORNIA – April 10, 2017 – Inari Medical Inc., a venture capital backed medical device company focused on the interventional treatment of venous thrombus, announced the treatment of the first patient with its ClotTriever Thrombectomy System. The ClotTriever Thrombectomy System received 510(k) marketing clearance from the U.S. Food and Drug Administration on February 16 for the non-surgical removal of thrombus (blood clots) from the peripheral vasculature.

+ Read More

Inari Medical Announces IDE Approval To Study The Flowtriever System For The Treatment Of Pulmonary Embolism

IRVINE, CALIFORNIA – March 8, 2016 – Inari Medical, Inc. announced today that it has received an Investigational Device Exemption (“IDE”) for a study to evaluate the safety and effectiveness of the FlowTriever Retrieval/Aspiration System. Ken Rosenfield, MD, Section Head for Vascular Medicine and Intervention, Massachusetts General Hospital and Victor Tapson, MD, Associate Director, Pulmonary and Critical Care Division, Cedars-Sinai Medical Center, Los Angeles are the Co-Principal Investigators of the study.

+ Read More

Inari Medical And Inceptus Medical Announce Receipt Of TCT Innovation Award

IRVINE, CALIFORNIA, November 23, 2015 – Inari Medical, Inc. and Inceptus Medical LLC announced today that the Inari FlowTriever® Retrieval /Aspiration System for thrombectomy received a 1st place Innovation Award at the 2015 Transcatheter Therapeutics (TCT) conference in San Francisco.

“We are pleased to have the FlowTriever thrombectomy system showcased at such a large and prestigious venue as TCT,” says Bill Hoffman, President and CEO of Inari. Bob Rosenbluth, President of Inceptus added, “We are proud to have Inari get this recognition at the largest medical device conference for interventional therapy. This is a nice honor as we initiate our pivotal trial to investigate the use of the FlowTriever specifically for the treatment of pulmonary embolism.”

+ Read More

Inari Medical Announces Closing of $12.4 Million Venture Financing

IRVINE, CALIFORNIA, June 30, 2015 – Inari Medical, Inc. announced today that it has closed a $12.4 million Series B venture capital financing. The financing was led by members of the board of directors and returning investors Versant Ventures and US Venture Partners. The round also included participation by several medical device industry veterans.

“We are very pleased to complete this financing with the support of new and existing investors,” said Bill Hoffman, who joined in February 2015 as President and Chief Executive Officer. “These funds will allow us to significantly enhance company value with continued product improvements and clinical studies that demonstrate the value of the FlowTriever™ Retrieval/Aspiration System in several markets with important unmet needs.” The FlowTriever is an FDA cleared, catheter-based thrombectomy device shown to extract significant amounts of clot from large vessels. “Inari’s approach to emboli retrieval is novel. It provides the interventionalist with a tool that can substantially reduce the need for thrombolytics, which carry unacceptably high risk for many patients,” added Bob Rosenbluth, Chairman and Co-founder.

+ Read More

Inari Medical Announces First Patient Treated with the FlowTriever Infusion Aspiration System Following 510(k) Clearance

IRVINE, CALIFORNIA, March 12, 2015 – Inari Medical Inc., a venture capital backed medical device company focused on the interventional treatment of vascular thrombus and emboli, announced the treatment of the first patient with its FlowTriever Infusion Aspiration System. The FlowTriever System received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) in February to treat emboli (blood clots) in the peripheral vasculature.

“We are pleased to be the first site to perform a procedure using the FlowTriever System,” said Dr. Tod Engelhardt, MD, chairman of the Cardiovascular and Thoracic Surgery Division of East Jefferson General Hospital in Metairie, Louisiana. “The FlowTriever offered an efficient, minimally invasive treatment and rapidly restored blood flow in the occluded vessel. I believe the FlowTriever is a promising new advancement in the treatment of vessels occluded by emboli.”

“The FlowTriever System is the first offering in Inari’s planned product portfolio,” said Bill Hoffman, Inari’s chief executive officer. “This device will be available for embolus treatment in peripheral applications at select centers and we plan to add additional centers as we gain clinical experience. We are pleased to provide a new tool for interventionalists to deal with emboli and rapidly restore flow in occluded vessels.” added Mr. Hoffman.

+ Read More

Bill Hoffman Joins Inari Medical as President and Chief Executive Officer

IRVINE, CALIFORNIA, February 9, 2015 – Bill Hoffman brings proven record of success in commercializing innovative therapies

Inari Medical, a medical device company pioneering innovative devices for the interventional treatment of cardiovascular disease announced today that Bill Hoffman has joined the company as President and Chief Executive Officer. A veteran medical device executive, Bill brings more than 25 years of experience to the role. Most recently, Bill served as President and CEO of Visualase, acquired by Medtronic in July 2014.

“We are delighted to welcome Bill to Inari,” said Bob Rosenbluth, Chairman of Inari’s Board of Directors and President and CEO of Inceptus. “He is an exceptional leader with a proven record of success in bringing innovative new therapies to market. I am confident that Bill’s strong commercial experience will serve Inari well in introducing its novel interventional system.”

+ Read More

Inceptus Announces Completion Of Series A Financing For Inari Medical

ALISO VIEJO, CALIFORNIA, October 16, 2013 – Versant Ventures and U.S. Venture Partners back medical device start-up.

Inceptus Medical, LLC, a medical device company incubator, announced today that it has completed a $4.7M Series A financing for its first new company, Inari Medical Inc. The financing will provide the resources to develop and commercialize innovative devices for the interventional treatment of cardiovascular disease.

Versant Ventures and U.S. Venture Partners (USVP) led the funding round. “My colleagues at Versant and I are excited to be working with Inceptus to develop new medical device companies,” said Kirk Nielsen, Managing Director at Versant Ventures. Kirk Nielsen and Don Milder at Versant Ventures and Jonathan Root, M.D. at USVP will serve as board members.

+ Read More